![MediciNova, Inc. logo](/logos/MNOV.webp)
MediciNova, Inc.
NASDAQ:MNOV
Overview | Financials
Company Name | MediciNova, Inc. |
Symbol | MNOV |
Currency | USD |
Price | 2.1 |
Market Cap | 102,997,020 |
Dividend Yield | 0% |
52-week-range | 1.12 - 2.38 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Yuichi Iwaki M.D., Ph.D. |
Website | https://www.medicinova.com |
An error occurred while fetching data.
About MediciNova, Inc.
MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. The company is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological disorders, such as primary and secondary progressive multiple
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD